# One Health Company (FidoCure)

> One Health Company, known to vets and pet parents as FidoCure, brings human-grade precision oncology to dogs. It sequences canine tumors, pinpoints cancer-driving mutations, and uses an AI engine (Fetch) trained on the world's largest structured canine cancer dataset to recommend targeted, FDA-approved therapies. Because dog and human cancers share genetics, the company is also building a comparative-oncology data asset that could accelerate cancer drug development for both species.

- **Founded:** 2016
- **Headquarters:** Palo Alto, California, United States
- **Founders:** Christina Lopes (Co-Founder & CEO), Benjamin Lewis (Co-Founder & Chief Strategy Officer)
- **Team size:** ~19 employees
- **Products:** FidoCure Precision Medicine Platform, Fetch AI Engine, Canine Cancer Genomic Dataset, Targeted Therapeutics Pipeline
- **Notable:** Built the world's largest structured canine cancer dataset - over 2 billion data points from ~1,350 clinics., Granted an industry-first US patent (Aug 2024) for AI-driven drug development targeting canine cancer., Launched the Fetch AI engine (Jan 2025) using real-world evidence from ~6,000 dogs.

## Products & services

- **FidoCure Precision Medicine Platform** — Genomic sequencing of a dog's tumor to identify cancer-driving mutations, paired with AI-enabled, mutation-matched targeted therapy recommendations that veterinarians can prescribe.
- **Fetch AI Engine** — Proprietary AI engine (launched Jan 2025) that analyzes real-world evidence from thousands of treated canine cancer cases to optimize and recommend therapies.
- **Canine Cancer Genomic Dataset** — The world's largest structured canine cancer dataset - over 2 billion data points drawn from ~1,350 veterinary clinics - powering biomarker discovery and drug development.
- **Targeted Therapeutics Pipeline** — A growing portfolio of biomarker-driven, repurposed and novel cancer therapies, backed by an industry-first patent and several pending patents.

## Achievements

- Built the world's largest structured canine cancer dataset - over 2 billion data points from ~1,350 clinics.
- Granted an industry-first US patent (Aug 2024) for AI-driven drug development targeting canine cancer.
- Launched the Fetch AI engine (Jan 2025) using real-world evidence from ~6,000 dogs.
- Backed by Andreessen Horowitz and Y Combinator from the earliest stage.
- Peer-reviewed research published in Nature and other journals.
- Available in all 50 US states through participating veterinarians.

## Latest updates

- **2025-01** — Launched Fetch, an AI engine that analyzes real-world evidence from thousands of canine cancer cases to optimize therapy recommendations.
- **2024-08** — Received an industry-first US patent for AI-driven drug development and a novel targeted therapy/biomarker for canine cancer (including bladder cancer).
- **2020-11** — Closed a $10M Series A led by Polaris Partners and Borealis Ventures to expand access to precision cancer treatment for dogs.

## Links

- Website: https://fidocure.com
- LinkedIn: http://www.linkedin.com/company/onehealthco
- Twitter/X: https://twitter.com/fidocure
- Instagram: https://www.instagram.com/fidocure
- Facebook: https://facebook.com/FidoCure/

---

Profile page: https://yespress.io/one-health-company
Published by YesPress — https://yespress.io
Last updated: 2026-06-13